Krsnaa Diagnostics Limited

NSEI:KRSNAA Stock Report

Market Cap: ₹20.9b

Krsnaa Diagnostics Balance Sheet Health

Financial Health criteria checks 6/6

Krsnaa Diagnostics has a total shareholder equity of ₹8.8B and total debt of ₹1.7B, which brings its debt-to-equity ratio to 18.8%. Its total assets and total liabilities are ₹12.8B and ₹4.0B respectively. Krsnaa Diagnostics's EBIT is ₹1.0B making its interest coverage ratio 4.1. It has cash and short-term investments of ₹684.4M.

Key information

18.75%

Debt to equity ratio

₹1.66b

Debt

Interest coverage ratio4.1x
Cash₹684.36m
Equity₹8.83b
Total liabilities₹3.99b
Total assets₹12.82b

Recent financial health updates

Recent updates

Earnings Miss: Krsnaa Diagnostics Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts

May 17
Earnings Miss: Krsnaa Diagnostics Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts

There's Been No Shortage Of Growth Recently For Krsnaa Diagnostics' (NSE:KRSNAA) Returns On Capital

Mar 21
There's Been No Shortage Of Growth Recently For Krsnaa Diagnostics' (NSE:KRSNAA) Returns On Capital

Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 17
Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
author-image

Expansion Into Underpenetrated Markets Will Increase Access To Advanced Diagnostic Services

Expansion into Tier 2 and 3 cities and strategic partnerships in healthcare sectors are expected to drive revenue growth and improve profit margins.

After Leaping 30% Krsnaa Diagnostics Limited (NSE:KRSNAA) Shares Are Not Flying Under The Radar

Nov 26
After Leaping 30% Krsnaa Diagnostics Limited (NSE:KRSNAA) Shares Are Not Flying Under The Radar

Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50

Sep 06
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50

Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50

Aug 23
Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50

Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 10
Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50

Aug 09
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50

Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors

Jul 05
Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors

Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return

Jun 16
Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return

We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings

May 26
We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings

Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?

Mar 14
Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?

Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 16
Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models

Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Aug 31
Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Aug 17
Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)

Jun 03
Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)

Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 17
Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)

Feb 16
Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)

Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think

Nov 17
Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think

Financial Position Analysis

Short Term Liabilities: KRSNAA's short term assets (₹4.1B) exceed its short term liabilities (₹3.1B).

Long Term Liabilities: KRSNAA's short term assets (₹4.1B) exceed its long term liabilities (₹934.4M).


Debt to Equity History and Analysis

Debt Level: KRSNAA's net debt to equity ratio (11%) is considered satisfactory.

Reducing Debt: KRSNAA had negative shareholder equity 5 years ago, but is now positive and has therefore improved.

Debt Coverage: KRSNAA's debt is well covered by operating cash flow (52.8%).

Interest Coverage: KRSNAA's interest payments on its debt are well covered by EBIT (4.1x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 00:38
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Krsnaa Diagnostics Limited is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hrishikesh PatoleBatlivala & Karani Securities India Pvt. Ltd.
Bharat CellyEquirus Securities Private Limited
Amey ChalkeJM Financial Institutional Securities Limited